Researcher
Guy Bormans
- Disciplines:Other chemical sciences, Chemical product design and formulation, Biomaterials engineering, Medical imaging and therapy, Medicinal products
Affiliations
- Radiopharmaceutical Research (Division)
Responsible
From1 Oct 2014 → Today - Radiopharmaceutical Research (Division)
Member
From1 Oct 1999 → Today
Projects
1 - 10 of 39
- Research on radioactive nuclei at ISOLDE-CERN, SPIRAL2- GANIL and MEDICIS-CERNFrom1 Jan 2023 → TodayFunding: FWO International research infrastructure (IRI)
- Development of TRNT radiopharmaceuticals targeting Hsp90From1 Oct 2022 → 31 Dec 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- IMAGINATION : IMAGing bIomarkers for diagNosis, therAnosTIcs and drug develOpmeNtFrom1 Oct 2022 → TodayFunding: IOF - mandates
- Translational investigation of the role of Hsp90 in neurodegenerative proteinopathies using positron emission tomography (PET)From1 Jan 2022 → TodayFunding: FWO research project (including WEAVE projects)
- Targeting radionuclides to tumors expressing extracellular Hsp90 using rationally designed peptide probesFrom22 Jun 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Peptide based CXCR4 targeting for PET imaging and radionuclide therapyFrom1 Jan 2021 → TodayFunding: Foundations, funds and other with scientific goal
- Unfolding the role of Hsp90 in brain: a multidisciplinary translational approachFrom1 Jun 2020 → 31 May 2022Funding: BOF - various
- Terbium labeling of anti-CEA nanobodies for in vivo imaging and therapy of colorectal cancerFrom1 Jan 2020 → 31 Dec 2020Funding: FWO research grant KAN
- Protein aggregation and folding as target for molecular imaging and radionuclide therapyFrom1 Oct 2019 → 30 Sep 2023Funding: IOF - technology concept exploration
- Click chemistry Options for Live Immuno Brain ImagingFrom1 Oct 2019 → 30 Sep 2021Funding: H2020 - Skills and Career Development (Marie Skłodowska-Curie) actions
Publications
1 - 10 of 286
- Highlight selection of radiochemistry and radiopharmacy developments by editorial board(2023)
Authors: Guy Bormans
- Synthesis, Structure-Activity Relationships, Radiofluorination, and Biological Evaluation of [18F]RM365, a Novel Radioligand for Imaging the Human Cannabinoid Receptor Type 2 (CB2R) in the Brain with PET(2023)
Authors: Guy Bormans
Pages: 13991 - 14010 - Preclinical Evaluation of Novel PET Probes for Dementia(2023)
Authors: Romy Cools, Kobe Kerkhofs, Renan Leitao, Guy Bormans
Pages: 599 - 629 - In vivo performance of different 18F-labelled cannabinoid receptor 2 radioligands(2023)
Authors: Guy Bormans
Pages: S255 - S255 - Impact on clinical management when using [18F]AlFNOTA-octreotide instead of [68Ga]Ga-DOTA-SSA PET/CT in neuroendocrine tumor patients: preliminary results(2023)
Authors: Jeroen Dekervel, Frederik Cleeren, Michel Koole, Guy Bormans, Chris Verslype, Christophe Deroose
Pages: S508 - S508 - Radiopharmaceuticals for Cancer Imaging and Therapy(2023)
Authors: Guy Bormans, Frederik Cleeren
- Reverse engineering synthetic antiviral amyloids (vol 11, 2832, 2020)(2023)
Authors: Emiel Michiels, Rodrigo Gallardo, Laleh Khodaparast, Ladan Khodaparast, Rob van der Kant, Bert Houben, Nikolaos Louros, Suzanne Kaptein, Guy Bormans, Johan Neyts, et al.
- Prospective comparison of [18F]AlF-NOTA-octreotide PET/MRI to [68Ga]Ga-DOTATATE PET/CT in neuroendocrine tumor patients(2023)
Authors: Frederik Cleeren, Jeroen Dekervel, Michel Koole, Guy Bormans, Annouschka Laenen, Paul Clement, Kristiaan Nackaerts, Chris Verslype, Koen Van Laere, Christophe Deroose
- 18F-AlF-NOTA-Octreotide Outperforms 68Ga-DOTATATE/ NOC PET in Neuroendocrine Tumor Patients: Results from a Prospective, Multicenter Study(2023)
Authors: Elin Pauwels, Frederik Cleeren, Michel Koole, Jeroen Dekervel, Annouschka Laenen, Paul Clement, Chris Verslype, Guy Bormans, Christophe Deroose
Pages: 632 - 638 - Direct comparison of [18F]AlF-NOTA-JR11 and [18F]AlF-NOTA-octreotide for PET imaging of neuroendocrine tumors: Antagonist versus agonist(2023)
Authors: Stephen Ahenkorah, Christopher Cawthorne, Christophe Deroose, Thomas Cardinaels, Guy Bormans, Frederik Cleeren
Patents
1 - 4 of 4